Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy
NCT01449279
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Melanoma
Interventions
DRUG:
Ipilimumab
RADIATION:
Radiation Therapy
Sponsor
Stanford University